APA
Cantú-Rodríguez O. G., Vázquez-Mellado A., González-Treviño J. L., Martínez-Garza D. M., Gómez-De León A., Hawing-Zarate J. A., Jaime-Pérez J. C., Gutierrez-Aguirre C. H., Garza-Acosta A. C., Mancías-Guerra C., González-Llano O., González-Cantú G. A., Herrera-Rojas M. A., Sada-Ovalle I. & Gómez-Almaguer D. (20201029). Cyclosporine A for the Prevention of Ocular Graft versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is Safe and Feasible. : Acta haematologica.
Chicago
Cantú-Rodríguez Olga Graciela, Vázquez-Mellado Alberto, González-Treviño Juan Luis, Martínez-Garza David Mauricio, Gómez-De León Andrés, Hawing-Zarate José Angel, Jaime-Pérez José Carlos, Gutierrez-Aguirre César Homero, Garza-Acosta Andrea Cecilia, Mancías-Guerra Consuelo, González-Llano Oscar, González-Cantú Graciela Alejandra, Herrera-Rojas Miguel Angel, Sada-Ovalle Isabel and Gómez-Almaguer David. 20201029. Cyclosporine A for the Prevention of Ocular Graft versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is Safe and Feasible. : Acta haematologica.
Harvard
Cantú-Rodríguez O. G., Vázquez-Mellado A., González-Treviño J. L., Martínez-Garza D. M., Gómez-De León A., Hawing-Zarate J. A., Jaime-Pérez J. C., Gutierrez-Aguirre C. H., Garza-Acosta A. C., Mancías-Guerra C., González-Llano O., González-Cantú G. A., Herrera-Rojas M. A., Sada-Ovalle I. and Gómez-Almaguer D. (20201029). Cyclosporine A for the Prevention of Ocular Graft versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is Safe and Feasible. : Acta haematologica.
MLA
Cantú-Rodríguez Olga Graciela, Vázquez-Mellado Alberto, González-Treviño Juan Luis, Martínez-Garza David Mauricio, Gómez-De León Andrés, Hawing-Zarate José Angel, Jaime-Pérez José Carlos, Gutierrez-Aguirre César Homero, Garza-Acosta Andrea Cecilia, Mancías-Guerra Consuelo, González-Llano Oscar, González-Cantú Graciela Alejandra, Herrera-Rojas Miguel Angel, Sada-Ovalle Isabel and Gómez-Almaguer David. Cyclosporine A for the Prevention of Ocular Graft versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is Safe and Feasible. : Acta haematologica. 20201029.